User profiles for Wallis CY Lau

Wallis CY Lau

UCL School of Pharmacy, University College London
Verified email at ucl.ac.uk
Cited by 2416

Prevention of dabigatran-related gastrointestinal bleeding with gastroprotective agents: a population-based study

EW Chan, WCY Lau, WK Leung, MTC Mok, Y He… - Gastroenterology, 2015 - Elsevier
Background & Aims Use of dabigatran, an inhibitor of thrombin, increases the risk of
gastrointestinal bleeding (GIB). However, it is not clear whether gastroprotective agents (GPAs) …

Association between dabigatran vs warfarin and risk of osteoporotic fractures among patients with nonvalvular atrial fibrillation

WCY Lau, EW Chan, CL Cheung, CW Sing, KKC Man… - Jama, 2017 - jamanetwork.com
Importance The risk of osteoporotic fracture with dabigatran use in patients with nonvalvular
atrial fibrillation (NVAF) is unknown. Objective To investigate the risk of osteoporotic fracture …

Psychotropic medicine consumption in 65 countries and regions, 2008–19: a longitudinal study

…, CSL Chui, JF Hayes, KKC Man, WCY Lau… - The Lancet …, 2021 - thelancet.com
Background The WHO Comprehensive Mental Health Action Plan 2013–2030 encourages
routine collection and reporting of a set of essential mental health indicators, including the …

[HTML][HTML] Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study

…, YH Jani, Y Hsia, ICK Wong, WCY Lau - The Lancet Public …, 2022 - thelancet.com
Background Previous studies have reported an extremely unbalanced global access to opioid
analgesics. We aimed to determine contemporary trends and patterns of opioid analgesic …

Comparative effectiveness and safety between apixaban, dabigatran, edoxaban, and rivaroxaban among patients with atrial fibrillation: a multinational population …

WCY Lau, CO Torre, KKC Man, HM Stewart… - Annals of Internal …, 2022 - acpjournals.org
Background: Current guidelines recommend using direct oral anticoagulants (DOACs) over
warfarin in patients with atrial fibrillation (AF), but head-to-head trial data do not exist to …

Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study

…, P Ip, D Coghill, E Simonoff, PKL Chan, WCY Lau… - bmj, 2017 - bmj.com
Objective To assess the potential association between prenatal use of antidepressants and
the risk of attention-deficit/hyperactivity disorder (ADHD) in offspring. Design Population …

Association of risk of suicide attempts with methylphenidate treatment

KKC Man, D Coghill, EW Chan, WCY Lau… - JAMA …, 2017 - jamanetwork.com
Importance Patients with attention-deficit/hyperactivity disorder (ADHD) are at an increased
risk of attempting suicide. Stimulants, such as methylphenidate hydrochloride, are the most …

Impact of pneumococcal conjugate vaccines on childhood otitis media in the United Kingdom

WCY Lau, M Murray, A El-Turki, S Saxena, S Ladhani… - Vaccine, 2015 - Elsevier
… Yingfen Hsia and Wallis Lau carried out the final data analyses, drafted the initial
manuscript, revised the manuscript, and approved the final manuscript as submitted. All authors …

Association between prenatal exposure to antipsychotics and attention-deficit/hyperactivity disorder, autism spectrum disorder, preterm birth, and small for gestational …

…, AYL Chan, D Coghill, P Ip, WCY Lau… - JAMA internal …, 2021 - jamanetwork.com
Importance The risk of birth and neurodevelopmental complications with prenatal exposure
to antipsychotics is unclear. Objective To evaluate the association between prenatal …

[HTML][HTML] Trends in lipid-modifying agent use in 83 countries

…, Y Wei, KKW Yap, H Alwafi, TT Ma, R Brauer, WCY Lau… - Atherosclerosis, 2021 - Elsevier
Background and aims Lipid-modifying agents (LMAs) are increasingly used to reduce lipid
levels and prevent cardiovascular events but the magnitude of their consumption in different …